Diagnosis of Down syndrome at 11 weeks is best assessed by:
Down syndrome, or Trisomy 21, is typically diagnosed through a combination of screening and diagnostic tests. In early pregnancy, the first-trimester screening usually includes nuchal translucency (NT) measurement via ultrasound, along with maternal serum markers like PAPP-A and free β-hCG. However, these are screening tests, not diagnostic. For a definitive diagnosis, invasive procedures such as chorionic villus sampling (CVS) or amniocentesis are used. CVS is typically performed between 10-13 weeks, which aligns with the 11-week timeframe mentioned here. Amniocentesis is usually done later, around 15-20 weeks.
Now, considering the options, the correct answer should be CVS. The other options might include NT scan, serum markers, or maybe others like non-invasive prenatal testing (NIPT), which is a screening tool but not diagnostic. The key is that the question asks for the best method to assess, which implies a diagnostic test. So, if the options include CVS, that's the answer. If not, maybe another option is present. But since the user hasn't provided the actual options, I need to assume based on common distractors.
The core concept here is understanding the timing and types of tests for Down syndrome. The correct answer is CVS because it allows karyotype analysis, providing a definitive diagnosis. The other options are either screening methods (NT, serum markers) or performed later (amniocentesis). Clinical pearl: Remember that CVS is done in the first trimester for early diagnosis, while amniocentesis is second trimester. Also, NIPT is a screening test with high accuracy but not diagnostic. So, in an exam, if the question is about the best diagnostic test at 11 weeks, CVS is the answer.
**Core Concept**
Diagnosis of Down syndrome (Trisomy 21) in early pregnancy involves **definitive chromosomal analysis**. **Chorionic villus sampling (CVS)** is the gold standard for first-trimester diagnostic testing, enabling karyotype confirmation between 10–13 weeks.
**Why the Correct Answer is Right**
CVS directly samples placental chorionic villi, which share the same genetic material as the fetus. This allows **karyotyping** to detect trisomy 21. It is **safe and accurate** at 11 weeks, with results available within 1–2 weeks. Unlike screening tests (e.g., nuchal translucency or serum markers), CVS provides a **definitive diagnosis**, not just risk stratification.
**Why Each Wrong Option is Incorrect**
**Option A:** *Nuchal translucency (NT) ultrasound* is a **screening tool**, not diagnostic. It assesses fetal neck fluid but has false positives/negatives.
**Option B:** *First-trimester combined screening (NT + PAPP-A/β-hCG)* quantifies risk but cannot confirm Down syndrome.
**Option C